Capitalization of the Purchaser. The entire authorized capital stock and other equity securities of the Purchaser consist of 100,000,000 shares of common stock with a par value of $0.001 (the “Purchaser Common Stock”). As of the date of this Agreement, there are 45,500,000 shares of Purchaser Common Stock issued and outstanding. All of the issued and outstanding shares of Purchaser Common Stock have been duly authorized, are validly issued, were not issued in violation of any pre-emptive rights and are fully paid and non-assessable, are not subject to pre-emptive rights and were issued in full compliance with all federal, state, and local laws, rules and regulations. There are no outstanding options, warrants, subscriptions, phantom shares, conversion rights or other rights, agreements or commitments obligating the Purchaser to issue any additional shares of Purchaser Common Stock, or any other securities convertible into, exchangeable for, or evidencing the right to subscribe for or acquire from the Purchaser any shares of Purchaser Common Stock as of the date of this Agreement. There are no agreements purporting to restrict the transfer of the Purchaser Common Stock, no voting agreements, voting trusts or other arrangements restricting or affecting the voting of the Purchaser Common Stock.
Appears in 2 contracts
Samples: Asset Acquisition Agreement (A5 Laboratories Inc.), Asset Acquisition Agreement (A5 Laboratories Inc.)
Capitalization of the Purchaser. The entire authorized capital stock and other equity securities of the Purchaser consist of 100,000,000 75,000,000 shares of common stock with a par value of $0.001 (the “Purchaser Common Stock”). As of the date of this Agreement, there are 45,500,000 16,735,000 shares of Purchaser Common Stock issued and outstanding. All of the issued and outstanding shares of Purchaser Common Stock have been duly authorized, are validly issued, were not issued in violation of any pre-emptive rights and are fully paid and non-assessable, are not subject to pre-emptive rights and were issued in full compliance with all federal, state, and local laws, rules and regulations. There are no outstanding options, warrants, subscriptions, phantom shares, conversion rights or other rights, agreements or commitments obligating the Purchaser to issue any additional shares of Purchaser Common Stock, or any other securities convertible into, exchangeable for, or evidencing the right to subscribe for or acquire from the Purchaser any shares of Purchaser Common Stock as of the date of this Agreement. There are no agreements purporting to restrict the transfer of the Purchaser Common Stock, no voting agreements, voting trusts or other arrangements restricting or affecting the voting of the Purchaser Common Stock.
Appears in 1 contract
Capitalization of the Purchaser. The entire authorized capital stock and other equity securities of the Purchaser consist of 100,000,000 shares of common stock with a par value of $0.001 0.00001 (the “"Purchaser Common Stock”"). As of the date of this Agreement, there are 45,500,000 6,500,000 shares of Purchaser Common Stock issued and outstanding. All of the issued and outstanding shares of Purchaser Common Stock have been duly authorized, are validly issued, were not issued in violation of any pre-emptive rights and are fully paid and non-assessable, are not subject to pre-emptive rights and were issued in full compliance with all federal, state, and local laws, rules and regulations. There are no outstanding options, warrants, subscriptions, phantom shares, conversion rights or other rights, agreements or commitments obligating the Purchaser to issue any additional shares of Purchaser Common Stock, or any other securities convertible into, exchangeable for, or evidencing the right to subscribe for or acquire from the Purchaser any shares of Purchaser Common Stock as of the date of this Agreement. There are no agreements purporting to restrict the transfer of the Purchaser Common Stock, no voting agreements, voting trusts or other arrangements restricting or affecting the voting of the Purchaser Common Stock.
Appears in 1 contract
Capitalization of the Purchaser. The entire authorized capital stock and other equity securities of the Purchaser consist of 100,000,000 150,000,000 shares of common stock and 100,000,000 shares of preferred stock, with a par value of $0.001 0.00001 (the “Purchaser Common Stock”). As of the date of this Agreement, there are 45,500,000 98,900,000 shares of Purchaser Common Stock issued and outstanding. All of the issued and outstanding shares of Purchaser Common Stock have been duly authorized, are validly issued, were not issued in violation of any pre-emptive rights and are fully paid and non-assessable, are not subject to pre-emptive rights and were issued in full compliance with all federal, state, and local laws, rules and regulations. There are no outstanding options, warrants, subscriptions, phantom shares, conversion rights or other rights, agreements or commitments obligating the Purchaser to issue any additional shares of Purchaser Common Stock, or any other securities convertible into, exchangeable for, or evidencing the right to subscribe for or acquire from the Purchaser any shares of Purchaser Common Stock as of the date of this Agreement. There are no agreements purporting to restrict the transfer of the Purchaser Common Stock, no voting agreements, voting trusts or other arrangements restricting or affecting the voting of the Purchaser Common Stock.
Appears in 1 contract
Samples: Asset Acquisition Agreement (Medical Care Technologies Inc.)